A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma

Clin Endocrinol (Oxf). 2015 Apr;82(4):598-603. doi: 10.1111/cen.12562. Epub 2014 Sep 1.

Abstract

Objective: Serum calcitonin (CT) level is used to detect medullary thyroid carcinoma (MTC), but the cut-off level is unclear. We aimed at identifying the optimal cut-off value of basal serum CT levels for detecting MTC.

Design and patients: We retrospectively enrolled patients with hypercalcitoninemia (≥2·9 pmol/l) who had undergone thyroid ultrasonography (US) and subsequent work-up between 2001 and 2013 at Asan Medical Center. We divided patients into four groups: proven MTC (group 1, n = 93), pathologically proven non-MTC after surgery (group 2, n = 57), benign single nodule by cytology (group 3, n = 68) and patients without nodules on US (group 4, n = 24).

Measurement: Basal serum CT levels were evaluated.

Results: The median CT level of group 1 (119·5 pmol/l) was significantly higher than those of other groups (4·0, 3·8 and 3·8 pmol/l, P < 0·001). When we adopted 19·0 pmol/l of CT level as a cut-off value, the sensitivity, specificity, and positive and negative predictive values were 77·4%, 98·7%, 97·3% and 87·8%, respectively. When we compared 29·2 pmol/l (100 pg/ml) and 19·0 pmol/l (65 pg/ml) as cut-off values, 19·0 pmol/l was more sensitive and accurate than 29·2 pmol/l. Factors associated with hypercalcitoninemia in non-MTC groups were autoimmune thyroiditis, chronic kidney disease, proton pump inhibitors and other malignancies. Serum CT levels tended to decrease spontaneously in non-MTC groups.

Conclusion: Basal serum CT levels higher than 19·0 pmol/l can be a useful cut-off value for detecting macroscopic MTC, even though values below 19·0 pmol/l cannot exclude the presence of MTC like small volume MTC or premalignant C-cell hyperplasia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / metabolism
  • Calcitonin / blood*
  • Carcinoma, Medullary / blood
  • Carcinoma, Medullary / congenital*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Medical Oncology / standards
  • Middle Aged
  • Multiple Endocrine Neoplasia Type 2a / blood*
  • Predictive Value of Tests
  • Proton Pump Inhibitors / therapeutic use
  • Renal Insufficiency, Chronic / blood
  • Renal Insufficiency, Chronic / diagnostic imaging
  • Reproducibility of Results
  • Retrospective Studies
  • Sensitivity and Specificity
  • Thyroid Gland / diagnostic imaging
  • Thyroid Neoplasms / blood*
  • Thyroiditis, Autoimmune / blood
  • Thyroiditis, Autoimmune / diagnostic imaging
  • Ultrasonography

Substances

  • Biomarkers, Tumor
  • Proton Pump Inhibitors
  • Calcitonin

Supplementary concepts

  • Familial medullary thyroid carcinoma